118 related articles for article (PubMed ID: 10430756)
1. Allograft vasculopathy: diagnosing the nemesis of heart transplantation.
Young JB
Circulation; 1999 Aug; 100(5):458-60. PubMed ID: 10430756
[No Abstract] [Full Text] [Related]
2. Role of dobutamine stress echocardiography for diagnosis of cardiac allograft vasculopathy.
Spes CH; Klauss V; Mudra H; Schnaack SD; Tammen AR; Rieber J; Uberfuhr P; Reichart B; Theisen K; Angermann CE
Transplant Proc; 1998 May; 30(3):904-6. PubMed ID: 9595141
[No Abstract] [Full Text] [Related]
3. Diagnostic and prognostic value of serial dobutamine stress echocardiography for noninvasive assessment of cardiac allograft vasculopathy: a comparison with coronary angiography and intravascular ultrasound.
Spes CH; Klauss V; Mudra H; Schnaack SD; Tammen AR; Rieber J; Siebert U; Henneke KH; Uberfuhr P; Reichart B; Theisen K; Angermann CE
Circulation; 1999 Aug; 100(5):509-15. PubMed ID: 10430765
[TBL] [Abstract][Full Text] [Related]
4. Allograft vasculopathy in cardiac transplant recipients: an early experience.
Trivedi S; Mullasari AS; Arumugam SB; Cherian KM
Indian Heart J; 1999; 51(5):548-50. PubMed ID: 10721649
[No Abstract] [Full Text] [Related]
5. 'Rapping' up cardiac allograft vasculopathy.
Khalpey Z; Kushwaha SS
Clin Cardiol; 2008 Jun; 31(6):286-7. PubMed ID: 17803252
[No Abstract] [Full Text] [Related]
6. [Use of imaging in the evaluation of heart transplant recipients].
De Chiara B; Roubina E; Frigerio M; Parodi O
Ital Heart J Suppl; 2005 Sep; 6(9):561-8. PubMed ID: 16281715
[TBL] [Abstract][Full Text] [Related]
7. Low-dose cyclosporine treatment fails to prevent coronary luminal narrowing after heart transplantation.
Vassalli G; Kaski JC; Tousoulis D; Kiowski W; Turina M; Follath F; Gallino A
J Heart Lung Transplant; 1996 Jun; 15(6):612-9. PubMed ID: 8794036
[TBL] [Abstract][Full Text] [Related]
8. Quantitative myocardial contrast echocardiography: a new method for the non-invasive detection of chronic heart transplant rejection.
Rutz T; de Marchi SF; Roelli P; Gloekler S; Traupe T; Steck H; Eshtehardi P; Cook S; Vogel R; Mohacsi P; Seiler C
Eur Heart J Cardiovasc Imaging; 2013 Dec; 14(12):1187-94. PubMed ID: 23612502
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the progression of cardiac allograft vasculopathy by dobutamine stress echocardiography.
Derumeaux G; Redonnet M; Soyer R; Cribier A; Letac B
J Heart Lung Transplant; 1998 Mar; 17(3):259-67. PubMed ID: 9563602
[TBL] [Abstract][Full Text] [Related]
10. Dobutamine stress echocardiography for noninvasive diagnosis of cardiac allograft vasculopathy: a comparison with angiography and intravascular ultrasound.
Spes CH; Mudra H; Schnaack SD; Klauss V; Reichle FM; Uberfuhr P; Theisen K; Angermann CE
Am J Cardiol; 1996 Jul; 78(2):168-74. PubMed ID: 8712138
[TBL] [Abstract][Full Text] [Related]
11. Optical coherence tomography and highly sensitivity troponin T for evaluating cardiac allograft vasculopathy.
Garrido IP; García-Lara J; Pinar E; Pastor-Pérez F; Sánchez-Mas J; Valdés-Chavarri M; Pascual-Figal DA
Am J Cardiol; 2012 Sep; 110(5):655-61. PubMed ID: 22640973
[TBL] [Abstract][Full Text] [Related]
12. Dobutamine stress echocardiography for detection of transplant coronary vasculopathy: comparison with angiography and intracoronary ultrasound.
Spes CH; Mudra H; Schnaack SD; Klauss V; Rieber J; Reichle F; Krüger TM; Uberfuhr P; Angermann CE; Theisen K
Transplant Proc; 1995 Jun; 27(3):1973-4. PubMed ID: 7792855
[No Abstract] [Full Text] [Related]
13. Cardiogenic shock and coronary endothelial dysfunction predict cardiac allograft vasculopathy after heart transplantation.
Lopez-Fernandez S; Manito-Lorite N; Gómez-Hospital JA; Roca J; Fontanillas C; Melgares-Moreno R; Azpitarte-Almagro J; Cequier-Fillat A
Clin Transplant; 2014 Dec; 28(12):1393-401. PubMed ID: 25284267
[TBL] [Abstract][Full Text] [Related]
14. Impact of coronary endothelial dysfunction on adverse long-term outcome after heart transplantation.
Kübrich M; Petrakopoulou P; Kofler S; Nickel T; Kaczmarek I; Meiser BM; Reichart B; von Scheidt W; Weis M
Transplantation; 2008 Jun; 85(11):1580-7. PubMed ID: 18551063
[TBL] [Abstract][Full Text] [Related]
15. Qualitative and quantitative assessment of cardiac allograft vasculopathy by intravascular ultrasound.
Klauss V; Rieber J; Uberfuhr P; Theisen K; Mudra H
Transplant Proc; 1995 Jun; 27(3):1975-6. PubMed ID: 7792856
[No Abstract] [Full Text] [Related]
16. Coronary flow reserve in cardiac allograft vasculopathy.
Parameshwar J
Transplantation; 1999 Nov; 68(10):1435-6. PubMed ID: 10589935
[No Abstract] [Full Text] [Related]
17. Cytomegalovirus infection associated accelerated heart allograft arteriosclerosis may impair the late function of the graft.
Koskinen P; Lemstrøm K; Mattila S; Häyry P; Nieminen MS
Clin Transplant; 1996 Dec; 10(6 Pt 1):487-93. PubMed ID: 8996768
[TBL] [Abstract][Full Text] [Related]
18. [Diagnosis of rejection after heart transplantation].
Nunoda S
Kyobu Geka; 2007 Jul; 60(8 Suppl):685-91. PubMed ID: 17763670
[TBL] [Abstract][Full Text] [Related]
19. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients.
Eisen HJ; Tuzcu EM; Dorent R; Kobashigawa J; Mancini D; Valantine-von Kaeppler HA; Starling RC; Sørensen K; Hummel M; Lind JM; Abeywickrama KH; Bernhardt P;
N Engl J Med; 2003 Aug; 349(9):847-58. PubMed ID: 12944570
[TBL] [Abstract][Full Text] [Related]
20. Influence of donor and recipient gender on cardiac allograft vasculopathy. An intravascular ultrasound study.
Mehra MR; Stapleton DD; Ventura HO; Escobar A; Cassidy CA; Smart FW; Collins TJ; Ramee SR; White CJ
Circulation; 1994 Nov; 90(5 Pt 2):II78-82. PubMed ID: 7955289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
